Altered expression of epimorphin in ulcerative colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 5, 2003, Pages 570-577

  Shirasaka, Tomoyuki ^a   Iizuka, Masahiro ^a   Yukawa, Michihiro ^a   Hirai, Yohei ^b   Horie, Yasuo ^a   Itou, Hiroaki ^a   Kon No, Shiho ^a   Fukushima, Tsuneo ^c   Watanabe, Sumio ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yokohama Municipal Hospital   (Japan)

^c AKITA UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor; Crohn's disease; Epimorphin; Ulcerative colitis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PROTEIN; SYNTAXIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

EID: 0037716543     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02972.x     Document Type: Article

References (29)

1. Kato K, Chen MM, Nguyen M, Lehmann FS, Podolsky DK, Soll AH. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures. Am. J. Physiol. 1999; 276: G1105-16.
2. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides. J. Gastroenterol. 2000; 35: 69-74.
3. Taupin DR, Kinoshita K, Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc. Natl Acad. Sci. USA 2000; 97: 799-804.
4. Bousvaros A, Leichtner A, Zurakowski D et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig. Dis. Sci. 1999; 44: 424-30.
5. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am. J. Gastroenterol. 2001; 96: 822-8.
6. Thorn M, Raab Y, Larsson A, Gerdin B, Hallgren R. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis. Scand. J. Gastroenterol. 2000; 35: 408-12.
7. Bousvaros A, Zurakowski D, Fishman SJ et al. Serum basic fibroblast growth factor in pediatric Crohn's disease: implications for wound healing. Dig. Dis. Sci. 1997; 42: 378-86.
8. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000; 47: 63-73.
9. Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JAW, Pender SLF. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 2000; 47: 57-62.
10. Hirai Y, Tanabe K, Takashima M, Kobayashi S, Takeichi M. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 1992; 69: 471-81.
11. Pelham HR. Is epimorphin involved in vesicular transport? Cell 1993; 73: 425-6.
12. Hirai Y, Nakagawa S, Takeichi M. Reexamination of the properties of epimorphin and its possible roles. Cell 1993; 73: 426-7.
13. Gumbiner BM. Epithelial morphogenesis. Cell 1992; 69: 385-7.
14. Aalto MK, Ronne H, Keranen S. Yeast syntaxins Sso1p and Sso2p belong to a family of related membrane proteins that function in vesicular transport. EMBO J. 1993; 12: 4095-104.
15. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 1998; 140: 159-69.
16. Goyal A, Singh R, Swietlicki EA, Levin MS, Rubin DC. Characterization of rat epimorphin/syntaxin 2 suggests a role in crypt-villus morphogenesis. Am. J. Physiol. 1998; 275: G114-24.
17. Plateroti M, Rubin DC, Duluc I et al. Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics. Am. J. Physiol. 1998; 274: G945-54.
18. Iizuka M, Chiba M, Yukawa M et al. Immunohistochemical analysis of the distribution of measles antigen in the intestinal mucosa in inflammatory bowel disease. Gut 2000; 46: 163-9.
19. Iizuka M, Saito H, Yukawa M et al. No evidence of persistent mumps virus infection in inflammatory bowel disease. Gut 2001; 48: 637-41.
20. Pande P, Mathur M, Shukla NK, Ralhan R. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J. Pathol. 1999; 189: 40-5.
21. Lehnert L, Lerch MM, Hirai Y, Kruse ML, Schmiegel W. Autocrine stimulation of human pancreatic duct-like development by soluble isoforms of epimorphin in vitro. J. Cell Biol. 2001; 152: 911-21.
22. Hirai Y. Molecular cloning of human epimorphin: identification of isoforms and their unique properties. Biochem. Biophys. Res. Commun. 1993; 191: 1332-7.
23. Akiyama M, Amagai M, Smith LT, Hashimoto K, Shimizu H, Nishikawa T. Epimorphin expression during human foetal hair follicle development. Br. J. Dermatol. 1999; 141: 447-52.
24. Koshida S, Hirai Y. Identification of cellular recognition sequence of epimorphin and critical role of cell/epimorphin interaction in lung branching morphogenesis. Biochem. Biophys. Res. Commun. 1997; 234: 522-5.
25. Nagamatsu S, Sawa H, Nakamichi Y, Kondo Y, Matsushiya S, Watanabe T. Non-functional role of syntaxin 2 in insulin exocytosis by pancreatic beta cells. Cell Biochem. Funct. 1997; 15: 237-42.
26. Watanabe S, Hirose M, Xian EW et al. A novel hepatic stellate (Ito) cell-derived protein, epimorphin, plays a key role in the late stages of liver regeneration. Biochem. Biophys. Res. Commun. 1998; 250: 486-90.
27. Hirose M, Watanabe S, Miyazaki A et al. [The expression of epimorphin in human liver.] Jpn. Pharmacol. Ther. 1998; 26: 137-9 (in Japanese).
28. Zhang L, Ishikawa O, Takeuchi Y, Miyachi Y. Immunohistochemical distribution of epimorphin in human and mouse tissues. Histochem. J. 1998; 30: 903-8.
29. Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand. J. Gastroenterol. 1999; 34: 55-67.